This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Asthma
and you are
between 18 and 65
years old
Phase
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This study will explore the utility of magnetic resonance imaging (MRI) to assess ventilatory defects that occur due to asthma, determine the sensitivity and specificity of MRI in response to drug treatment, and whether MRI can serve as a biomarker of treatment effects due to asthma therapy.

Provided treatments

  • Drug: Montelukast
  • Drug: Prednisone
Tris trial is registered with FDA with number: NCT01621386. The sponsor of the trial is Hal C Charles and it is looking for 34 volunteers for the current phase.
Official trial title:
A Study Comparing Measures of Ventilatory Heterogeneity (VH) in Asthma Patients